News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,805 Results
Type
Article (42886)
Company Profile (437)
Press Release (671482)
Section
Business (209119)
Career Advice (2067)
Deals (36104)
Drug Delivery (103)
Drug Development (83682)
Employer Resources (173)
FDA (16478)
Job Trends (15159)
News (353504)
Policy (33176)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2651)
Accelerated approval (5)
Adcomms (25)
Allergies (82)
Alliances (51043)
ALS (88)
Alzheimer's disease (1411)
Antibody-drug conjugate (ADC) (124)
Approvals (16461)
Artificial intelligence (251)
Autoimmune disease (19)
Automation (14)
Bankruptcy (373)
Best Places to Work (11878)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (331)
Bladder cancer (63)
Brain cancer (25)
Breast cancer (261)
Cancer (2080)
Cardiovascular disease (174)
Career advice (1727)
Career pathing (29)
CAR-T (148)
Cell therapy (421)
Cervical cancer (19)
Clinical research (67631)
Collaboration (814)
Compensation (475)
Complete response letters (26)
COVID-19 (2644)
CRISPR (40)
C-suite (225)
Cystic fibrosis (103)
Data (2019)
Decentralized trials (2)
Denatured (26)
Depression (47)
Diabetes (259)
Diagnostics (6448)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (119)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (92)
Earnings (87534)
Editorial (36)
Employer branding (21)
Employer resources (147)
Events (115659)
Executive appointments (671)
FDA (17625)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (727)
Gene editing (106)
Generative AI (20)
Gene therapy (305)
GLP-1 (724)
Government (4495)
Grass and pollen (4)
Guidances (49)
Healthcare (19215)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (27)
Infectious disease (2779)
Inflammatory bowel disease (139)
Inflation Reduction Act (11)
Influenza (49)
Intellectual property (88)
Interviews (325)
IPO (16789)
IRA (44)
Job creations (3744)
Job search strategy (1467)
Kidney cancer (9)
Labor market (34)
Layoffs (492)
Leadership (17)
Legal (8010)
Liver cancer (71)
Lung cancer (301)
Lymphoma (136)
Machine learning (4)
Management (58)
Manufacturing (277)
MASH (64)
Medical device (13541)
Medtech (13546)
Mergers & acquisitions (19790)
Metabolic disorders (672)
Multiple sclerosis (74)
NASH (19)
Neurodegenerative disease (93)
Neuropsychiatric disorders (30)
Neuroscience (1934)
NextGen: Class of 2025 (6798)
Non-profit (4561)
Northern California (2491)
Now hiring (37)
Obesity (362)
Opinion (223)
Ovarian cancer (74)
Pain (83)
Pancreatic cancer (77)
Parkinson's disease (144)
Partnered (20)
Patents (207)
Patient recruitment (99)
Peanut (47)
People (58640)
Pharmaceutical (86)
Pharmacy benefit managers (20)
Phase I (21249)
Phase II (29845)
Phase III (22080)
Pipeline (1085)
Podcasts (75)
Policy (124)
Postmarket research (2605)
Preclinical (9071)
Press Release (67)
Prostate cancer (97)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (387)
Real estate (6037)
Recruiting (66)
Regulatory (22702)
Reports (46)
Research institute (2422)
Resumes & cover letters (355)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (73)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (56)
Southern California (2166)
Special edition (18)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (3774)
State (2)
Stomach cancer (14)
Supply chain (62)
Tariffs (11)
The Weekly (47)
United States (22040)
Vaccines (678)
Venture capitalists (38)
Webinars (13)
Weight loss (244)
Women's health (35)
Worklife (17)
Date
Last 7 days (680)
Last 30 days (2486)
Last 365 days (34465)
2025 (8579)
2024 (36464)
2023 (41114)
2022 (52362)
2021 (56840)
2020 (55036)
2019 (47620)
2018 (35826)
2017 (33281)
2016 (32554)
2015 (38543)
2014 (32294)
2013 (27243)
2012 (29331)
2011 (29977)
2010 (28103)
Location
Africa (747)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (39314)
Australia (6542)
California (5732)
Canada (1896)
China (488)
Colorado (256)
Connecticut (274)
Delaware (131)
Europe (86066)
Florida (834)
Georgia (196)
Idaho (58)
Illinois (524)
India (24)
Indiana (298)
Iowa (10)
Japan (145)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (866)
Massachusetts (4408)
Michigan (211)
Minnesota (380)
Mississippi (2)
Missouri (79)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (66)
New Jersey (1635)
New Mexico (30)
New York (1629)
North Carolina (994)
North Dakota (7)
Northern California (2491)
Ohio (195)
Oklahoma (14)
Oregon (37)
Pennsylvania (1287)
Puerto Rico (9)
Rhode Island (28)
South America (1125)
South Carolina (18)
South Dakota (1)
Southern California (2166)
Tennessee (95)
Texas (856)
Utah (168)
Virginia (135)
Washington D.C. (59)
Washington State (539)
West Virginia (3)
Wisconsin (57)
714,805 Results for "x biotix therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PRECISIO BIOTIX THERAPEUTICS ANNOUNCES COLLABORATION WITH MAYO CLINIC
Precisio Biotix Therapeutics (“Precisio”) today announced it has entered into an agreement with Mayo Clinic.
March 14, 2024
·
3 min read
Deals
Precisio Biotix Therapeutics Acquires London-Headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists
Precisio Biotix Therapeutics announced the acquisition of CC Bio, creator of the ZEUS anti-bacterial lysin platform.
March 1, 2024
·
4 min read
Business
PRECISIO BIOTIX THERAPEUTICS EXPANDS THE US MANAGEMENT TEAM WITH THE HIRING OF DR. RAYMOND SCHUCH
Precisio Biotix Therapeutics (“Precisio”) today announced the hiring of Dr. Raymond (Ray) Schuch as Vice President, Director of US Operations.
January 23, 2024
·
2 min read
BioCapital
PRECISIO BIOTIX TO PRESENT AT BIOTECH SHOWCASE™ 2024 and BFC GLOBAL HEALTHCARE CONFERENCE
Precisio Biotix today announced that it is presenting at both the BFC Global Healthcare Conference and Biotech Showcase™ 2024.
January 5, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
Precision X-Ray, Inc. Partners with Gilardoni SpA to Deliver X-Ray Blood Irradiation in the US
October 16, 2024
·
2 min read
Genetown
X-Biotix Therapeutics Announces Change in Corporate Strategy
X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of first-in-class antibiotic compounds targeting multi-drug-resistant Gram-negative pathogens, announced today a change in its strategy, which will include suspension of its current antibacterial research efforts.
April 26, 2021
·
4 min read
Press Releases
Scribe Therapeutics Presents Data on its Epigenetic Long-Term X-Repressor Technology at the 2025 Keystone Symposia on Precision Genome Engineering Conference
March 7, 2025
·
3 min read
Press Releases
TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering
March 26, 2025
·
4 min read
1 of 71,481
Next
